Publications
3 shownOsimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
In patients with stage IB to IIIA <i>EGFR</i> mutation-positive NSCLC, disease-free survival was significantly longer among those who received osimertinib than among those who r...
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Lobectomy is the standard of care for early-stage non-small-cell lung cancer (NSCLC). The survival and clinical benefits of segmentectomy have not been investigated in a randomi...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 7,777
- Institution
- National Cancer Center Hospital East
External Links
Identifiers
- ORCID
- 0000-0003-3031-5807
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.